Australia, Dec. 11 -- Recce Pharmaceuticals Ltd. (RCE) has reported gross short sales of 35,232 FPO shares on Dec. 9. The percent of issued capital of the company reported as short sales is 0.01 percent. The issued capital of the company is 231,871,617 shares.
Disclaimer: Curated by HT Syndication.
